TUBA1B and metabolic dysfunction-associated steatohepatitis: Although this previous study did not address the etiology of HCCs with TUBA1B overexpression, the present study clearly revealed that alterations of TUBA1B gene DNA methylation had already occurred at the precancerous NASH stage (Fig. 2) and in a NASH-specific manner (Fig. 3).